Ziel des Projekts ist die Identifizierung ursächlicher Sequenzvarianten im Genom von Patienten mit seltenen Erkrankungen.
Support for small and medium-sized life sciences companies to enter challenging global markets.
The Bavarian lighthouse project for digitization in the health sector.
BioM is leading a network of Bavarian biotechnological companies focusing on immunotherapy.
Promoting collaborations between Bavarian biotechnological companies and Japanese pharmaceutical companies as well as scientific institutions in Japan.
Peer2scale, an HORIZON 2020 project, is a peer-learning action between four regional health agencies acting as clusters.
BioM co-ordinates and organizes the "Round Table of Clinical Research" developed within the scope of the Bavarian "Pharmagipfel" conference with representatives of medical centers and the industry.